June 2019

Is your European high yield easy to trade when it matters?

In European high yield, both bond and CDS indices saw high volatility in May.

Source: Bloomberg, 31 May 2019. Past performance is not a reliable indicator of future performance.

In this situation, funds tracking bond indices tend to trade at a discount because of liquidity issues in the underlying bonds. This may make redemptions more costly.

In contrast, CDS indices tend to be more liquid at times of stress, as seen in the below chart showing the jump in trading volumes in the iTraxx Crossover 5y in May, when spreads widened by over 50bps. Because they allow you to trade credit risk without trading the underlying bonds, these indices are becoming the default option for large market participants.

Source: Bloomberg, 31 May 2019.

Our long and short European Crossover UCITS ETFs allow you to benefit from this enhanced liquidity; they directly replicate the iTraxx European Crossover Long Credit (ITRXXOVL) and iTraxx European Crossover Short Credit (ITRXXOVS) indices.

ITRXXOVS takes an inverse position in European high yield credit via a protection buyer position on the iTraxx Crossover 5y. The strategy, which tends to profit from spread widening, particularly during rapid sell-offs, was up 2.9% in May.

It has an inverse correlation with the ITRXXOVL Index which takes a protection seller position on the iTraxx Crossover and fell 2.4% during the same period.

	10y return (ann.)	10y volatility	10y correl. v. ITRXXOVS
iTraxx European Crossover Short Credit Index (ITRXXOVS)	-8.9%	7.6%	1.00
iTraxx European Crossover Long Credit Index (ITRXXOVL)	8.3%	7.3%	-0.99
Markit iBoxx EUR Liquid High Yield Index TR	8.1%	6.4%	-0.85

Source: Tabula, Bloomberg, 31 May 2019. Past performance is not a reliable indicator of future performance.

Visit our product pages to learn about our ETFs for gaining efficient exposure to ITRXXOVS and ITRXXOVL:

• TECC – Long European Crossover, tracking ITRXXOVL
• TECS – Short European Crossover, tracking ITRXXOVS

Important Information

This document is issued by Cheyne Capital Management (UK) LLP (“Cheyne Capital”), a limited liability partnership registered in England and Wales (Registered no. OC321484 – registered address: 6th Floor, Denham Building, 27 St. James’s Street, London, SW1A 1HA). Cheyne Capital is authorised and regulated by the Financial Conduct Authority (“FCA”). Tabula Investment Management Limited (“Tabula”) is an Appointed Representative of Cheyne Capital. Tabula is a private limited company registered in England and Wales (Registered no. 11286661). Business address: Sixth Floor, Denham Building, 27 St. James’s Street, SW1A 1HA, London.

This material is for distribution to Professional Clients (as defined by the FCA or MiFID Rules) and Qualified Investors only and should not be relied upon by any other persons. Tabula has not considered the suitability of this investment against your individual needs and risk tolerance. The data displayed provides summary information, any decision to invest must be based solely on the information contained in the Fund’s Prospectus, Key Investor Information Document and the latest half-yearly report and unaudited accounts and/or annual report and audited accounts, when available, free from your broker, financial adviser or Tabula Investment Management Limited. It is the responsibility of every person reading this document to satisfy himself as to the full observance of the laws of any relevant country, including obtaining any government or other consent which may be required or observing any other formality which needs to be observed in that country and which might be relevant to the subscription, purchase, holding, exchange, redemption or disposal of any investments. No provider of information presented here, including index and ratings information is liable for damages or losses of any type arising from use of their information nor breach of such legislation or for any losses relating to the accuracy, completeness or use of information in this communication, including consequential loss. No warranty of accuracy is given and no liability in respect of any error or omission is accepted. No sale will be made in any jurisdiction in which the offer, solicitation, or sale is not authorised or to any person to whom it is unlawful to make the offer, solicitation or sale. This document does not constitute an offer to sell or solicitation of an offer to buy interests in any product and may not be used to make such an offer. The information contained in this document, especially as regards portfolio construction/parameter-type information, reflects the current thinking of Tabula IM and may be changed or modified in response to its perception of changing market conditions, or otherwise, without further notice to you. Accordingly, the information herein, in respect of investment products and services, should be considered indicative of Tabula IM current opinion and should not be relied on in making any investment decisions. This document is not, and under no circumstances is to be construed as an advertisement or any other step in furtherance of a public offering of shares in the United States or Canada. This document is not aimed at persons who are resident in the United States, Canada or any province or territory thereof, where the Fund/securities are not authorised or registered for distribution and where no prospectus has been filed with any securities commission or regulatory authority. The Fund/securities may not be acquired or owned by, or acquired with the assets of, an ERISA Plan. Investment in the products mentioned in this document may not be suitable for all investors. Past performance is not a guide to future performance and should not be the sole factor of consideration when selecting a product. The price of the investments may go up or down and the investor may not get back the amount invested. Your income is not fixed and may fluctuate. The value of investments involving exposure to foreign currencies can be affected by exchange rate movements. We remind you that the levels and bases of, and reliefs from, taxation can change. In respect of the products mentioned this document is intended for information purposes only and does not constitute investment advice or an offer to sell or a solicitation of an offer to buy the securities described within. In Switzerland, the Fund has appointed as Swiss representative Oligo Swiss Fund Services SA, Av. Villamont 17, 1005 Lausanne, Switzerland, Tel: +41 21 311 17 77, email: info@oligofunds.ch. The Fund’s Swiss paying agent is Banque Cantonale de Genève. The Prospectus, the Key Investor Information Documents, the Instrument of Incorporation as well as the annual and semi-annual reports may be obtained free of charge from the Swiss Representative in Lausanne. In respect of the Shares distributed in or from Switzerland, the place of performance and jurisdiction is at the registered office of the Swiss Representative. The issue and redemption prices are published at each issue and redemption on www.swissfunddata.ch. The iTraxx European Crossover Long Credit Index and iTraxx European Crossover Short Credit Index referenced herein are the property of Markit Indices Limited and are used under license.

© 2019 Tabula Investment Management Limited.